MedTrace Logo

PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer

NCT04119362 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 469

Last updated 2024-03-07

No results posted yet for this study

Summary

Due to the generally poor prognosis, with no chance of long-term survival, health related quality of life is a very important objective in the treatment of patients with pancreatic cancer. The non-interventional, prospective, multicentre PARAGON study is desinged to evaluate the health-related quality of life in patients with metastatic pancreatic cancer, by analyzing the course of QoL throughout all applied therapy lines for patients with pancreatic adenocarcinoma, measured according to EORTC scoring manual and patient reported outcome.

Conditions

  • Pancreatic Adenocarcinoma

Interventions

OTHER

Quality of live questionnaires

EORTC-Q30 questionnaire, additonal questionnaire on worries about quality of life impairments and on physical condition every 8 weeks. No additional visits will be carried out for questionnaires. Questionnaires will be handed out to patients during routine visits.

OTHER

Optional translational project

Collection of archival tumor material for future translational projects. No biopsy will be performed in the context of this registry. Only tumor samples obtained in the context of standard of care and after explicit informed context will be used.

Sponsors & Collaborators

  • Celgene

    collaborator INDUSTRY

  • Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

    lead OTHER

Principal Investigators

  • Salah-Eddin Al-Batran, Prof. · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

  • Thorsten Goetze, Prof. · Krankenhaus Nordwest gGmbH Institut für Klinisch-Onkologische Forschung

  • Ralf Hofheinz, Prof. · Universitätsmedizin Mannheim

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-24
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04119362 on ClinicalTrials.gov